Gabelli Funds’s Charles River Laboratories CRL Stock Holding History

Gabelli Funds’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.96M	Hold	19,500	–	–	0.02%	639
2025 Q1	$2.94M	Hold	19,500	–	–	0.02%	572
2024 Q4	$3.6M	Sell	19,500 -700	-3%	-$129K	0.03%	521
2024 Q3	$3.98M	Hold	20,200	–	–	0.03%	509
2024 Q2	$4.17M	Hold	20,200	–	–	0.03%	484
2024 Q1	$5.47M	Hold	20,200	–	–	0.04%	431
2023 Q4	$4.78M	Hold	20,200	–	–	0.04%	455
2023 Q3	$3.96M	Hold	20,200	–	–	0.03%	487
2023 Q2	$4.25M	Hold	20,200	–	–	0.03%	493
2023 Q1	$4.08M	Hold	20,200	–	–	0.03%	500
2022 Q4	$4.4M	Sell	20,200 -765	-4%	-$167K	0.03%	485
2022 Q3	$4.13M	Sell	20,965 -3,735	-15%	-$735K	0.03%	488
2022 Q2	$5.29M	Buy	24,700 +12,200	+98%	+$2.61M	0.04%	453
2022 Q1	$3.55M	Buy	12,500 +7,000	+127%	+$1.99M	0.02%	590
2021 Q4	$2.07M	Hold	5,500	–	–	0.01%	728
2021 Q3	$2.27M	Sell	5,500 -13,750	-71%	-$5.68M	0.02%	704
2021 Q2	$7.12M	Sell	19,250 -2,861	-13%	-$1.06M	0.05%	431
2021 Q1	$6.41M	Sell	22,111 -7,000	-24%	-$2.03M	0.04%	445
2020 Q4	$7.27M	Hold	29,111	–	–	0.05%	390
2020 Q3	$6.59M	Sell	29,111 -1,750	-6%	-$396K	0.05%	385
2020 Q2	$5.38M	Hold	30,861	–	–	0.04%	420
2020 Q1	$3.9M	Sell	30,861 -5,000	-14%	-$631K	0.03%	468
2019 Q4	$5.48M	Buy	35,861 +2,750	+8%	+$420K	0.04%	480
2019 Q3	$4.38M	Buy	33,111 +4,111	+14%	+$544K	0.03%	548
2019 Q2	$4.12M	Buy	29,000 +2,500	+9%	+$355K	0.03%	589
2019 Q1	$3.85M	Sell	26,500 -500	-2%	-$72.6K	0.02%	606
2018 Q4	$3.06M	Sell	27,000 -5,000	-16%	-$566K	0.02%	638
2018 Q3	$4.31M	Sell	32,000 -10,000	-24%	-$1.35M	0.02%	612
2018 Q2	$4.72M	Buy	42,000 +15,000	+56%	+$1.68M	0.03%	578
2018 Q1	$2.88M	Buy	27,000 +2,946	+12%	+$314K	0.02%	690
2017 Q4	$2.63M	Buy	24,054 +10,554	+78%	+$1.16M	0.02%	719
2017 Q3	$1.46M	Hold	13,500	–	–	0.01%	842
2017 Q2	$1.37M	Sell	13,500 -13,500	-50%	-$1.37M	0.01%	851
2017 Q1	$2.43M	Sell	27,000 -10,000	-27%	-$900K	0.01%	732
2016 Q4	$2.82M	Hold	37,000	–	–	0.02%	706
2016 Q3	$3.08M	Hold	37,000	–	–	0.02%	682
2016 Q2	$3.05M	Buy	37,000 +10,000	+37%	+$824K	0.02%	679
2016 Q1	$2.05M	Buy	+27,000	New	+$2.05M	0.01%	754